Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention

Medicine and Dentistry

• Ticlopidine 100%
• Thrombotic Thrombocytopenic Purpura 72%
• Apoplexy 63%
• Patient 54%
• Coronary Artery 45%
• Plasmapheresis 36%
• Stent Placement 27%
• Adverse Event 18%
• Antiplatelet Drug 18%
• Clinical Trial 18%
• Case Report 18%
• Diseases 9%
• Toxicity 9%
• Combination Therapy 9%
• Adverse Drug Reaction 9%
• Clopidogrel 9%
• Laboratory Test 9%
• High Risk Population 9%
• Life 9%
• Drug 9%
• Chemotherapeutic Agent 9%
• Woman 9%
• Inpatient 9%
• Physician 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Ticlopidine 100%
• Thrombotic Thrombocytopenic Purpura 72%
• Stent 72%
• Death 36%
• Adverse Event 18%
• Antithrombocytic Agent 18%
• Diseases 9%
• Toxicity 9%
• Clopidogrel 9%
• Adverse Drug Reaction 9%
• Drug 9%
• Postmarketing Surveillance 9%